Red Biotechnology (47)
White Biotechnology (40)
Green Biotechnology (29)
Blue Biotechnology (26)
Mount Sinai researchers discover technology that silences genes
Mount Sinai researchers have developed a new gene silencing technology that could be used to target genes that can lead to the development of certain diseases.
Synthetic moleculues could add spice to fight against cancer
Turning up the heat on the red tomato during processing has the potential to give the popular garden staple added disease-fighting power, Ohio State University research suggests.
Heart valves that grow with the patient
Successful transplantation of tissue engineered biological cardiac valves for children , which grow with the patients
Luminescence shines new light on proteins
A chance discovery by a team of scientists using optical probes means that changes in cells in the human body could now be seen in a completely different light.
Pure insulin-producing cells produced in mouse
Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs).
Spinning natural proteins into fabrics for new wound-repair products
Scientists in Israel are reporting the first successful spinning of a key natural protein into strong nano-sized fibers about 1/50,000th the width of a human hair.
Freeing protein-based drugs from bacteria’s natural traps
In a finding that could speed the development of new protein-based drugs for fighting diabetes, hepatitis, and other diseases, researchers are reporting progress toward preventing or destroying an unusual structure...
Cinnamon-based packaging to prevent mold in bread and other baked goods
Bread that goes moldy is the bane of consumers and bakers alike, ruining appetites and wasting food and money.
Generating embryonic stem cells
Embryonic stem cells, as their name suggests, are derived from embryos.
Detection of the pediocin gene pedA in strains from human faeces by real-time PCR and characterization of Pediococcus acidilactici UVA1
Bacteriocin-producing lactic acid bacteria are commonly used as natural protective cultures.
High performance microbiological transformation of L-tyrosine to L-dopa by Yarrowia lipolytica NRRL-143
The 3,4-dihydroxy phenyl L-alanine (L-dopa) is a drug of choice for Parkinson's disease, controlling changes in energy metabolism enzymes of the myocardium following neurogenic injury.
Human clones: New U.N. analysis lays out world's choices
Report says ban on human reproductive cloning, coupled with restricted therapeutic research, is global compromise most likely to succeed
Nano-sized voltmeter measures electric fields deep within cells
A wireless, nano-scale voltmeter developed at the University of Michigan is overturning conventional wisdom about the physical environment inside cells.
Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells
Method may provide a new diagnostic tool for cancer
Scripps scientists develop new tests that identify lethal prion strains quickly and accurately
Findings will significantly accelerate prion research
Nanotubes may have high-tech applications, study involving UCR engineers reports
Two engineers at the University of California, Riverside are part of a binational team that has found semiconducting nanotubes produced by living bacteria – a discovery that could help in the creation of a new generation of nanoelectronic devices.
Using carbon nanotubes to seek and destroy anthrax toxin and other harmful proteins
New technology could enable new cancer treatment techniques and antibacterial coatings
MIT sorts cells with beams of light
Could find applications in genetic screening, more
UCLA's California NanoSystems Institute partners with Abraxis BioScience
CNSI at UCLA today announced a partnership with the integrated global biopharmaceutical company Abraxis BioScience Inc. to collaborate on nanobiotechnology research for the advancement of new technologies in medicine.
Wiley-Blackwell announces launch of 'Microbial Biotechnology'
Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc, and the Society for Applied Microbiology (SfAM) announced today publication of the first articles for Microbial Biotechnology.